These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2501 related articles for article (PubMed ID: 7903405)

  • 21. Prognostic significance of PCNA grade in malignant melanoma.
    Woosley JT; Dietrich DR
    J Cutan Pathol; 1993 Dec; 20(6):498-503. PubMed ID: 7907615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma.
    Binder M; Dolezal I; Wolff K; Pehamberger H
    J Invest Dermatol; 1992 Aug; 99(2):180-3. PubMed ID: 1629630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of prognostic characteristics of stage I cutaneous malignant melanoma.
    Tan GJ; Baak JP
    Anal Quant Cytol; 1984 Sep; 6(3):147-54. PubMed ID: 6508033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
    Talve LA; Collan YU; Ekfors TO
    J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters.
    Soyer HP
    J Cutan Pathol; 1991 Aug; 18(4):264-72. PubMed ID: 1719049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometric analysis of melanocytic tumors. A study of nuclear area and density.
    Boivin C; Thomine E; Menard JF; Bigorgne C; Hemet J
    Am J Dermatopathol; 1994 Apr; 16(2):145-9. PubMed ID: 8030766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome.
    Amin MB; Ma CK; Linden MD; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1993 Oct; 100(4):428-32. PubMed ID: 8105676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
    Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
    Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased nuclear volume in metastasizing "thick" melanomas.
    Mossbacher U; Knollmayer S; Binder M; Steiner A; Wolff K; Pehamberger H
    J Invest Dermatol; 1996 Mar; 106(3):437-40. PubMed ID: 8648173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Karyometry of primary and metastatic malignant melanoma. A correlation with cell proliferation.
    Piérard-Franchimont C; Piérard GE
    Am J Dermatopathol; 1994 Jun; 16(3):247-52. PubMed ID: 7943630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
    Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
    Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen.
    Soyer HP; Smolle J; Smolle-Juettner FM; Kerl H
    Dermatologica; 1989; 179(1):3-9. PubMed ID: 2569990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
    Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
    Teague K; el-Naggar A
    Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of cytophotometric characteristics to histology and proliferation markers in acoustic neuromas.
    Welkoborsky HJ; Haibt G; Mann WJ; Amedee RG
    Ann Otol Rhinol Laryngol; 1994 Jan; 103(1):49-53. PubMed ID: 7904813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
    Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
    Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin.
    Talve L; Kainu J; Collan Y; Ekfors T
    Pathol Res Pract; 1996 Aug; 192(8):825-33. PubMed ID: 8897518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 126.